Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative furosemide versus placebo for urine output and postoperative kidney function in orthopedic surgery
IRCT20260104068540N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of furosemide (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: plasma creatinine level. Started Jan 2026; status: completed.
02
Drugs
furosemide
Beyond the preview
Go deeper on IRCT20260104068540N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260104068540N1.